eGenesis, Inc. — Form D

eGenesis, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-10. The offering totals $125.0M, of which $125.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Isaac CiechanoverDirectorCAMBRIDGE, MA
Peter HansonExecutive OfficerCAMBRIDGE, MA
Paul SekhriExecutive OfficerNew York, NY
Sapna SrivastavaExecutive OfficerBethesda, MD
Bob MoreDirectorVenice, CA
Steven GillisDirectorSouth San Francisco, CA
Boris NikolicDirectorAtlanta, GA
Geoff MacKayExecutive OfficerToronto, A6
Lucio IannoneDirectorWatertown, MA
Sarah SchlesingerDirectorCAMBRIDGE, MA
Mark PruzanskiDirectorCAMBRIDGE, MA
Brad SmithDirectorCAMBRIDGE, MA
Rahul KakkarDirectorCAMBRIDGE, MA
Albert WiegmanDirectorCAMBRIDGE, MA
Julie SunderlandDirectorCAMBRIDGE, MA
Michael CurtisDirectorCAMBRIDGE, MA
Michael CurtisExecutive OfficerCAMBRIDGE, MA
Jennifer BergheiserExecutive OfficerCAMBRIDGE, MA
Paul SekhriDirectorNew York, NY
Kathleen FanningDirectorCAMBRIDGE, MA
Kenneth FanExecutive OfficerDover, DE
Ariel JasieExecutive OfficerCAMBRIDGE, MA
Albert L WiegmanDirectorCAMBRIDGE, MA
Juergen L EckhardtDirectorCAMBRIDGE, MA
Lucio L IannoneDirectorCAMBRIDGE, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2024-02-27D$28.7M$25.4M
2019-11-14D$100.0M$100.0M
2017-03-23D$38.2M$12.6M
2016-08-23D$3.0M$2.0M

More